Notice of Results

EKF Diagnostics Holdings PLC

05 March 2026

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Notice of Results & Investor Presentations

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics business, will announce its full year results for the year ended 31 December 2025 on Tuesday 24 March 2026.

Investor presentations

Gavin Jones, CEO, and Stephen Young, CFO, will present the Company's results in two separate events open to all investors. The same presentation will be given at both events, which are being held at different times to offer convenient options for those wishing to attend.

Two presentations will take place on Tuesday 24 March 2026 at the following times, the first will be held online via the Investor Meet Company platform and the second will be held in-person in the City of London, full details below:

1.    Investor Meet Company online presentation

EKF management will provide a live online presentation relating to the final results via Investor Meet Company at 11:00am GMT on Tuesday 24 March 2026. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet EKF via:

https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor

A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

2.    In-person investor presentation

EKF management will provide an in-person presentation in the City of London relating to the Company's final results at 5.30pm GMT on Tuesday 24 March 2026, which is open to all existing and potential shareholders.

If you would like to attend, please contact Walbrook PR on 020 7933 8780 or email [e-mail].

The person responsible for arranging the release of this Announcement
on behalf of the Company is Gavin Jones, Chief Executive Officer.

EKF Diagnostics Holdings plc		www.ekfdiagnostics.com
Julian Baines, Executive Chair		via Walbrook PR
Gavin Jones, Chief Executive Officer
Singer Capital Markets (Nominated Adviser & Broker)			Tel: [phone]
Phil Davies / Patrick Weaver
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings	Mob: [phone]

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is an AIM-listed global diagnostics business focussed on:

●	Point-of-Care analysers in the key areas of Hematology and Diabetes
●	Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

END